In glioma cells, an increase in extracellular glutamate caused by overexpression of SLC7A11 impairs cytotoxic T-cell activation and promotes regulatory T (Treg)-cell proliferation, leading to intratumoral immunosuppression [60,61]. This evidence concerns the gene SLC7A11 and central nervous system cancer.